Monkeypox in Germany: Is there already a vaccination or medication?

Created: 05/24/2022, 13:51

By: Raffaela Maas

More and more cases of monkeypox are becoming known in Europe and the first case has now been officially confirmed in Germany.

But how can you protect yourself from infection and is there already a vaccination?

Munich – The UK Health Security Agency (UKHSA) reported the first case of monkeypox on May 14th.

Since then, suspected cases and evidence of monkeypox have been reported from more and more countries.

The first case in Germany has now been officially confirmed.

The outbreak raises many questions - including whether there is a protective vaccine.

Monkeypox in Germany: these are the symptoms

• Sudden onset of fever

• Head, muscle, neck and back pain

• chills

• Severely itchy rash typical of smallpox

• Swollen lymph nodes

Skin lesions in patients confirmed to have monkeypox.

© UKHSA/dpa

Monkeypox: how to protect yourself from transmission?

Monkeypox is transmitted through close contact with an infected person or animal.

Contact with lesions, body fluids, respiratory droplets, or material contaminated with the virus also leads to infection.

In order to protect yourself from infection with the virus, the Robert Koch Institute (RKI) advises avoiding contact with and consumption of potentially infected animals such as monkeys and various rodents in endemic areas.

Hygiene measures when dealing with sick people should also be strictly observed.

Monkeypox Outbreak: Is There a Vaccine?

There is currently no approved vaccination against monkeypox in Germany.

But according to the RKI, vaccination against smallpox also protects against monkeypox due to the similarity of the viruses.

In a tweet, University of Birmingham smallpox expert Jason Mercer said the vaccine was 85 percent effective against monkeypox four days after contact with an infected person.

also read

Monkeypox: Two new cases, first contacts in quarantine - Lauterbach wants to "react hard"

Monkeypox: Real Danger or Excessive Concern?

Virologist Sandra Ciesek explains

A smallpox vaccine containing modified vaccinia virus Ankara (MVA) has been approved in the EU.

This is a two-dose vaccine whose availability is still limited according to the WHO.

In the USA and Canada, the vaccine MVA-BN is also approved against monkeypox.

According to WHO, scientific studies are also underway to assess the feasibility and adequacy of vaccination to prevent and control monkeypox.

Infection with monkeypox: A drug provides relief

A medicine to treat orthopoxvirus infection was recently approved in the EU for the treatment of monkeypox by the European Medical Association (EMA).

The so-called tecovirimate works by interacting with a protein on the surface of the pathogen and preventing it from multiplying.

According to the WHO, however, the antiviral agent is not yet available across the board.